Popular weight-loss drugs, including Ozempic, Wegovy, Trulicity and Mounjaro, produced by independent pharmacy labs, sickened some 8,000 or more Marylanders a year by 2024. The Food and Drug ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro ...

Novo Nordisk brought in Justin Long and John Hodgman, who had been in the Apple "Get A Mac" ads from 20 years ago, to star in ...

Better known by their brand names like Ozempic and Mounjaro, the popularity of GLP-1s has soared in recent years. As fakes ...

The new NICE guidance recommends that most people should now be offered metformin along with an SGLT-2 inhibitor from the start, while also advising that they get a slow-release formulation of ...

Winfrey has openly discussed her weight-loss journey and the use of prescription GLP-1 medications in recent years.

Eli Lilly and Company (NYSE:LLY) Q4 2025 Earnings Call Transcript February 4, 2026 Eli Lilly and Company beats earnings expectations. Reported EPS is $7.54, expectations were $6.91. Operator: Thanks ...

A massive review of 23 randomized trials found that statins do not cause the vast majority of side effects listed on their ...

A new study shows that people are likely to continue taking GLP-1 drugs like Ozempic, which is commonly prescribed off-label for weight loss, despite side effects like nausea, diarrhea, and abdominal ...

Most statin side effects listed on drug packaging are not supported by strong evidence, a new review suggests. Of 66 potential side effects, researchers identified only 4 linked to statins.